A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma (Q43837271)
Jump to navigation
Jump to search
scientific article published in October 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma |
scientific article published in October 2001 |
Statements
1 reference
A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma (English)
1 reference
S Halford
1 reference
D Yip
1 reference
C S Karapetis
1 reference
A H Strickland
1 reference
A Steger
1 reference
H T Khawaja
1 reference
P G Harper
1 reference
1 October 2001
1 reference
1 reference
Identifiers
1 reference